For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
After finishing at $5.25 in the prior trading day, Alector Inc (NASDAQ: ALEC) closed at $4.81, down -8.38%. In other words, the price has decreased by -$8.38 from its previous closing price. On the day, 0.51 million shares were traded. ALEC stock price reached its highest trading level at $5.2 during the session, while it also had its lowest trading level at $4.8.
Ratios:
Our goal is to gain a better understanding of ALEC by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.18 and its Current Ratio is at 3.18. In the meantime, Its Debt-to-Equity ratio is 0.29 whereas as Long-Term Debt/Eq ratio is at 0.23.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Stifel on December 14, 2023, Upgraded its rating to Buy and sets its target price to $15 from $8 previously.
On December 12, 2023, Deutsche Bank started tracking the stock assigning a Buy rating and target price of $12.
On September 25, 2023, Goldman started tracking the stock assigning a Sell rating and target price of $4.Goldman initiated its Sell rating on September 25, 2023, with a $4 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Mar 04 ’24 when Rosenthal Arnon sold 18,837 shares for $6.92 per share. The transaction valued at 130,386 led to the insider holds 2,000,380 shares of the business.
Kenkare-Mitra Sara sold 10,169 shares of ALEC for $70,387 on Mar 04 ’24. The President and Head of R&D now owns 318,847 shares after completing the transaction at $6.92 per share. On Mar 04 ’24, another insider, Romano Gary, who serves as the Chief Medical Officer of the company, sold 6,001 shares for $6.92 each. As a result, the insider received 41,554 and left with 196,313 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ALEC now has a Market Capitalization of 502683488 and an Enterprise Value of -49389064. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.75 while its Price-to-Book (P/B) ratio in mrq is 3.04. Its current Enterprise Value per Revenue stands at -0.509 whereas that against EBITDA is 0.338.
Stock Price History:
Over the past 52 weeks, ALEC has reached a high of $9.06, while it has fallen to a 52-week low of $3.66. The 50-Day Moving Average of the stock is -21.40%, while the 200-Day Moving Average is calculated to be -23.07%.
Shares Statistics:
The stock has traded on average 680.60K shares per day over the past 3-months and 481880 shares per day over the last 10 days, according to various share statistics. A total of 84.88M shares are outstanding, with a floating share count of 72.80M. Insiders hold about 23.96% of the company’s shares, while institutions hold 65.52% stake in the company. Shares short for ALEC as of 1713139200 were 6899317 with a Short Ratio of 10.14, compared to 1710460800 on 5846246. Therefore, it implies a Short% of Shares Outstanding of 6899317 and a Short% of Float of 9.1800004.
